60 Degrees Pharmaceuticals (SXTP) Receivables - Net (2022 - 2025)
60 Degrees Pharmaceuticals (SXTP) has disclosed Receivables - Net for 4 consecutive years, with $674036.0 as the latest value for Q3 2025.
- On a quarterly basis, Receivables - Net rose 108.15% to $674036.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $674036.0, a 108.15% increase, with the full-year FY2024 number at $486748.0, up 110.41% from a year prior.
- Receivables - Net was $674036.0 for Q3 2025 at 60 Degrees Pharmaceuticals, up from $295034.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $674036.0 in Q3 2025 to a low of $45965.0 in Q4 2022.
- A 4-year average of $311022.6 and a median of $296370.0 in 2024 define the central range for Receivables - Net.
- Peak YoY movement for Receivables - Net: soared 403.28% in 2023, then dropped 0.45% in 2025.
- 60 Degrees Pharmaceuticals' Receivables - Net stood at $45965.0 in 2022, then skyrocketed by 403.28% to $231332.0 in 2023, then soared by 110.41% to $486748.0 in 2024, then surged by 38.48% to $674036.0 in 2025.
- Per Business Quant, the three most recent readings for SXTP's Receivables - Net are $674036.0 (Q3 2025), $295034.0 (Q2 2025), and $488243.0 (Q1 2025).